bioRxiv · 10.64898/2025.12.22.695923
Systemic administration of PD-L1 blocking antibodies leads to removal of senescent microglia
Abstract
Senescent microglia develop during aging and Alzheimers disease (AD), driving chronic neuroinflammation. Here we hypothesized that the previously observed disease-modifying effects of PD-1/PD-L1 blockade occur through clearance of senescent microglia. Using CyTOF, we found that a single systemic anti-PD-L1 injection leads to rapid elimination of senescent microglia in 5xFAD and aged wild-type mice, independently of Fc effector function, while increasing homeostatic microglia. These findings suggest that immune rejuvenation via PD-L1 blockade promotes disease modification in AD through senescent-microglial elimination.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Androsova, Y., Kertser, A., Partney, H., Nathansohn, B., Ibraheem, A., Abellanas, M. A., Croese, T., Salame, T. M., Akiva, H., Krizhanovsky, V., Schwartz, M.. 2025-12-24. Systemic administration of PD-L1 blocking antibodies leads to removal of senescent microglia. https://doi.org/10.64898/2025.12.22.695923
Cite the original work for its findings. Save a collection to share your selection of sources.